NM_001184880.2(PCDH19):c.595G>C (p.Glu199Gln) AND Developmental and epileptic encephalopathy, 9
- Germline classification:
- Likely pathogenic (1 submission)
- Last evaluated:
- Jun 1, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002291243.1
Allele description [Variation Report for NM_001184880.2(PCDH19):c.595G>C (p.Glu199Gln)]
NM_001184880.2(PCDH19):c.595G>C (p.Glu199Gln)
Condition(s)
- Name:
- Developmental and epileptic encephalopathy, 9 (DEE9)
- Synonyms:
- EPILEPSY, FEMALE-RESTRICTED, WITH MENTAL RETARDATION; JUBERG-HELLMAN SYNDROME; PCDH19-Related X-Linked Female-Limited Epilepsy with Mental Retardation; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0010246; MedGen: C1848137; Orphanet: 2076; OMIM: 300088
-
kleisin beta (731)
PMC
-
SAMN25560368 (1)
SRA
-
breast cancer type 1 susceptibility protein isoform 109 [Homo sapiens]
breast cancer type 1 susceptibility protein isoform 109 [Homo sapiens]gi|2255444265|ref|NP_001395360.1|Protein
-
Overt Stroke
Overt StrokeMedGen
-
Supratentorial cancer
Supratentorial cancerMedGen
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Aug 5, 2023